Summarized by Masters of Longevity from Peter Attia Blog.
A long-form AMA reflects on changing positions across nutrition, pharmacologics, cancer screening, imaging, and exercise based on new evidence and clinical experience.
Key Takeaways
- Peter Attia says he stopped taking metformin for longevity based on evolving evidence and personal judgment.
- He expresses increasing uncertainty about rapamycin for humans despite compelling animal data and unresolved dosing questions.
- He revises exercise recommendations, moving away from heavy barbell squats and adjusting the 80/20 Zone 2 framework for limited training time.
